ClinConnect ClinConnect Logo
Search / Trial NCT02380001

Analgesic Preoperative/Postoperative Dexketoprofen Trometamol in Third Molar Surgery

Launched by DANIEL CHAVARRÍA BOLAÑOS · Feb 27, 2015

Trial Information

Current as of July 25, 2025

Completed

Keywords

Postoperative Pain Dexketoprofen Trometamol Third Molar Surgery

ClinConnect Summary

MODEL OF SURGICAL REMOVAL OF TOOTH IMPACTION. The model of Dental Impaction Pain Model (DIPM) is the most utilized of all the acute pain models. Its popularity is due to a well-established, well-validated, and extensively used postsurgery pain model in assessing the efficacy of analgesics on inflammatory pain.

The surgical procedure is very standardized and surgery require either minimal or nothing use of CNS depressant anesthetics. The methodology is similar to other models of acute pain; however, the DIPM is much more versatile than most other models. The model can be easily adapted to c...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Healthy volunteers between 18-28 years old
  • Clinical and radiographic diagnosis of impacted mandibular third molars, which the surgical approach may include flap and osteotomy procedures.
  • surgery classified as simple to moderate
  • Voluntary acceptance of written consent, previously approved by institutional ethics committee
  • Exclusion Criteria:
  • Prior administration of analgesic or anti-inflammatory drugs
  • History of drug dependence
  • History of allergic reactions to any of the drugs selected, or local anesthetics
  • Simultaneous presence of oral pathologies that may interfere with the surgical procedure

About Daniel Chavarría Bolaños

Daniel Chavarría Bolaños is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With extensive experience in the design and management of clinical studies, he focuses on innovative therapeutic interventions across various therapeutic areas. His approach emphasizes rigorous scientific methodology, ethical standards, and collaboration with healthcare professionals to ensure the highest quality of data and participant safety. Daniel is passionate about fostering a culture of transparency and integrity in clinical research, making significant contributions to the advancement of healthcare solutions.

Locations

San Luis Potosi, , Mexico

Patients applied

0 patients applied

Trial Officials

Amaury Pozos, PhD

Study Director

Universidad Autónoma de San Luis Potosí

Vicente Esparza, Resident

Principal Investigator

Universidad Autónoma de San Luis Potosí

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials